Mnemonic announced that it has receive notification of the allocation of financial support from the European Regional Development Fund (ERDF) under the FEDER-SSE+ program for Bourgogne Franche-Comté and Massif du Jura 2021-2027 program (Action ?PR1-RSO1.1-TA1 - Soutenir les projets de recherche collaboratifs dans les domaines de la stratégie de spécialisation intelligente? (Supporting collaborative research projects in the fields covered by the smart specialisation strategy)), aimed at improving research and innovation. Program COMETE (moleCular radiOtherapy for METastatic Colorectal and gastric cancErs) is an application to a regional FEDER-FSE+ call for projects.

It relates to the development of a radiotheranostic molecules portofolio for the treatment of advanced digestive cancers. The aim of the project is to develop one radiotheranostic candidate to pre-clinical dosimetry studies. The COMETE project is supported by OPM, the Centre de Lutte Contre le Cancer (CGFL) and the Institut de Chimie (ICMUB), all based in Dijon.

ERDF is providing the COMETE project with a grant totalling a maximum of ?7.8m (for a total project cost of ?9.2m), i.e. around 75% of the eligible amount, including ?2.1m for OPM, over a period of 5 years. It will contribute to progress research and development of a portfolio of radiotheranostic molecules to the pre-clinical stage. The internal vectorised radiotherapy (IVR) molecules will be developed to treat advanced digestive cancers, and their diagnostic companions will be developed to diagnose and monitor the same patients before and after IVR treatment.

This contribution from ERDF to the COMETE program strengthens Oncodesign Precision Medicine's position as a major player in the biotechnology sector in indications with a high medical need. This project, which will be developed in the Bourgogne Franche-Comté region, is part of a strong regional dynamic in favour of the development of biotechnologies and precision medicine.